PTX 8.70% 5.0¢ prescient therapeutics limited

updated chart, page-29

  1. 1,656 Posts.
    lightbulb Created with Sketch. 198
    Agree supertramp.., we will get a good idea into the efficacy of the ptx100. Worth reminding holders ( readers), that this particular study is a mono therapy and multi targeting ( a ‘marker’ hypothesised to incorporating multiple cancer triggers). Worth the wait (imo) on this basket trial.
    Luck to holders and volunteers alike.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.